ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
AtriCure, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026
$55.53−0.54 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $2.71B
- P/E (TTM)
- 264.4
- Dividend yield
- –
AtriCure, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $435.37M | $382.82M | $333.54M | $277.20M | $229.13M | $169.24M | $185.83M | $162.15M | $138.39M | $122.39M | 81.4% | +13.7% |
| Total International | $99.16M | $82.49M | $65.70M | $53.18M | $45.20M | $37.29M | $44.98M | $39.48M | $36.33M | $32.72M | 18.6% | +20.2% |
| Europe | $61.49M | $49.87M | $38.47M | $30.43M | $27.93M | $23.22M | $27.93M | $25.91M | $21.90M | $19.77M | 11.5% | +23.3% |
| Asia Pacific | $30.72M | $27.38M | $24.53M | $20.73M | $16.08M | – | – | – | – | – | 5.7% | +12.2% |
| Other International | $6.94M | $5.24M | $2.71M | $2.02M | $1.19M | $952.00K | $1.07M | $885.00K | $812.00K | $729.00K | 1.3% | +32.5% |
| Asia Pacific | – | – | – | $20.73M | $16.08M | $13.12M | $15.98M | $12.69M | $13.62M | $12.22M | – | – |
From the segment and revenue-disaggregation notes of AtriCure's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.